Your prediction
China SXT Pharmaceuticals Inc. Stock
Our community identified positive and negative aspects for China SXT Pharmaceuticals Inc. stock for the coming years. 1 users see the criterium "Revenue growth" as a plus for the China SXT Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of China SXT Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of China SXT Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Pacira Pharmaceuticals | 1.900% | 4.902% | 7.000% | 15.676% | 15.676% | -44.271% | -54.661% |
| Rockwell Medical Inc. | -0.990% | -5.729% | 2.046% | -58.951% | -60.417% | -16.440% | -92.115% |
| Twist Bioscience Corp | -2.080% | -5.009% | 14.014% | -41.746% | -42.357% | 6.269% | -77.276% |

